These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 21071432)

  • 1. Haploinsufficiency of the murine Col3a1 locus causes aortic dissection: a novel model of the vascular type of Ehlers-Danlos syndrome.
    Smith LB; Hadoke PW; Dyer E; Denvir MA; Brownstein D; Miller E; Nelson N; Wells S; Cheeseman M; Greenfield A
    Cardiovasc Res; 2011 Apr; 90(1):182-90. PubMed ID: 21071432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II promotes thoracic aortic dissections and ruptures in Col3a1 haploinsufficient mice.
    Faugeroux J; Nematalla H; Li W; Clement M; Robidel E; Frank M; Curis E; Ait-Oufella H; Caligiuri G; Nicoletti A; Hagege A; Messas E; Bruneval P; Jeunemaitre X; Bergaya S
    Hypertension; 2013 Jul; 62(1):203-8. PubMed ID: 23630948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
    Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
    Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical artery dissections and type A aortic dissection in a family with a novel missense COL3A1 mutation of vascular type Ehlers-Danlos syndrome.
    Makrygiannis G; Loeys B; Defraigne JO; Sakalihasan N
    Eur J Med Genet; 2015 Nov; 58(11):634-6. PubMed ID: 26497932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celiprolol but not losartan improves the biomechanical integrity of the aorta in a mouse model of vascular Ehlers-Danlos syndrome.
    Dubacher N; Münger J; Gorosabel MC; Crabb J; Ksiazek AA; Caspar SM; Bakker ENTP; van Bavel E; Ziegler U; Carrel T; Steinmann B; Zeisberger S; Meienberg J; Matyas G
    Cardiovasc Res; 2020 Feb; 116(2):457-465. PubMed ID: 31056650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model.
    D'hondt S; Guillemyn B; Syx D; Symoens S; De Rycke R; Vanhoutte L; Toussaint W; Lambrecht BN; De Paepe A; Keene DR; Ishikawa Y; Bächinger HP; Janssens S; Bertrand MJM; Malfait F
    Matrix Biol; 2018 Sep; 70():72-83. PubMed ID: 29551664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The haploinsufficient Col3a1 mouse as a model for vascular Ehlers-Danlos syndrome.
    Cooper TK; Zhong Q; Krawczyk M; Tae HJ; Müller GA; Schubert R; Myers LA; Dietz HC; Talan MI; Briest W
    Vet Pathol; 2010 Nov; 47(6):1028-39. PubMed ID: 20587693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of three Korean patients with clinical features of Ehlers-Danlos syndrome type IV.
    Yang JH; Lee ST; Kim JA; Kim SH; Jang SY; Ki CS; Kim DK
    J Korean Med Sci; 2007 Aug; 22(4):698-705. PubMed ID: 17728513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular Ehlers-Danlos syndrome: can the beneficial effect of celiprolol be extrapolated to bisoprolol?
    Gorosabel MC; Dubacher N; Meienberg J; Matyas G
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(3):199-200. PubMed ID: 31693161
    [No Abstract]   [Full Text] [Related]  

  • 10. Is Exon Skipping a Viable Therapeutic Approach for Vascular Ehlers-Danlos Syndrome with Mutations in
    Utama S; Cale JM; Mitrpant C; Fletcher S; Wilton SD; Aung-Htut MT
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-institutional experience in the aortic and arterial pathology in individuals with genetically confirmed vascular Ehlers-Danlos syndrome.
    Shalhub S; Byers PH; Hicks KL; Charlton-Ouw K; Zarkowsky D; Coleman DM; Davis FM; Regalado ES; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Behrendt CA; Debus ES; von Kodolitsch Y; Powell RJ; Pepin M; Milewicz DM; Lawrence PF; Woo K
    J Vasc Surg; 2019 Nov; 70(5):1543-1554. PubMed ID: 31126764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ehlers-Danlos syndrome type IV is associated with a novel G984R COL3A1 mutation.
    Deng Y; Wei S; Hu S; Chen J; Tan Z; Yang Y
    Mol Med Rep; 2015 Jul; 12(1):1119-24. PubMed ID: 25776230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ehlers-Danlos syndrome type IV, vascular type, which demonstrated a novel point mutation in the COL3A1 gene.
    Sadakata R; Hatamochi A; Kodama K; Kaga A; Yamaguchi T; Soma T; Usui Y; Nagata M; Ohtake A; Hagiwara K; Kanazawa M
    Intern Med; 2010; 49(16):1797-800. PubMed ID: 20720362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes.
    Shalhub S; Black JH; Cecchi AC; Xu Z; Griswold BF; Safi HJ; Milewicz DM; McDonnell NB
    J Vasc Surg; 2014 Jul; 60(1):160-9. PubMed ID: 24650746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.
    Kuivaniemi H; Tromp G
    Gene; 2019 Jul; 707():151-171. PubMed ID: 31075413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular Ehlers-Danlos Syndrome with a Novel Missense Mutation in COL3A1: A Man in His 50s with Aortic Dissection after Interventional Treatment for Hemothorax as the First Manifestation.
    Sakai K; Toda M; Kyoyama H; Nishimura H; Kojima A; Kuwabara Y; Kobayashi Y; Kikuchi S; Hirata Y; Moriyama G; Watanabe W; Akutsu K; Nakai M; Yamada T; Gemma A; Uematsu K
    Intern Med; 2019 Dec; 58(23):3441-3447. PubMed ID: 31391389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new COL3A1 mutation in Ehlers-Danlos syndrome type IV.
    Eder J; Laccone F; Rohrbach M; Giunta C; Aumayr K; Reichel C; Trautinger F
    Exp Dermatol; 2013 Mar; 22(3):231-4. PubMed ID: 23489429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-institutional experience in vascular Ehlers-Danlos syndrome diagnosis.
    Shalhub S; Byers PH; Hicks KL; Coleman DM; Davis FM; De Caridi G; Weaver KN; Miller EM; Schermerhorn ML; Shean K; Oderich G; Ribeiro M; Nishikawa C; Charlton-Ouw K; Behrendt CA; Debus ES; von Kodolitsch Y; Zarkowsky D; Powell RJ; Pepin M; Milewicz DM; Regalado ES; Lawrence PF; Woo K
    J Vasc Surg; 2020 Jan; 71(1):149-157. PubMed ID: 31353273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal type III collagen produced by an exon-17-skipping mutation of the COL3A1 gene in Ehlers-Danlos syndrome type IV is not incorporated into the extracellular matrix.
    Chiodo AA; Sillence DO; Cole WG; Bateman JF
    Biochem J; 1995 Nov; 311 ( Pt 3)(Pt 3):939-43. PubMed ID: 7487954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemizygous deletion of COL3A1, COL5A2, and MSTN causes a complex phenotype with aortic dissection: a lesson for and from true haploinsufficiency.
    Meienberg J; Rohrbach M; Neuenschwander S; Spanaus K; Giunta C; Alonso S; Arnold E; Henggeler C; Regenass S; Patrignani A; Azzarello-Burri S; Steiner B; Nygren AO; Carrel T; Steinmann B; Mátyás G
    Eur J Hum Genet; 2010 Dec; 18(12):1315-21. PubMed ID: 20648054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.